Nutrify Today, Pharma Eurasia, and Uzbekistan’s Ministry of Health formalise a structured Indo–CIS corridor, with Pharma Eurasia 2026 (Tashkent, 20–22 May) as the commercial execution platform.
- Oncology takes centre stage in Gilead’s new acquisition deal. - Gilead doubles down on CAR-T Therapy with Arcellx purchase, offering 79% higher on its shares. - Gilead Sciences is apparently dealing with declining sales for its COVID drug Veklury.
IAN Alpha Fund, the 2nd in the series of IAN Group’s VC funds, along with Speciale Invest, has co-led a ₹70 crore Series A funding round in Peptris, a Bengaluru-based AI-powered drug discovery company. The round also saw participation from Tenacity Ventures, BYT Ventures, and other investors. The investment
Sanofi, a French pharmaceutical giant, will increase its long-term presence in India by adding more than 4,500 jobs to its workforce at its global capabilities center (GCC) in Hyderabad. There are more than 2,600 people working at the centre right now. A "multi-hundred-million" investment will fund
Pandorum Technologies, a biotechnology company pioneering programmable regenerative medicine, with operations in India and the United States, has announced the closing of a US$18 million in Series B financing round, to advance the clinical development of its disease-modifying, tunable, exosome-based therapies, including Kuragenx, while scaling global manufacturing and expanding
Nutrify Today, the global catalyst for the nutraceutical industry, has premiered a landmark feature in its documentary series, Legends of Lifesciences, featuring Rajeev Juneja, Vice Chairman and Managing Director of Mankind Pharma. The documentary offers a rare, high-level perspective on the evolution of Indian healthcare, chronicling Juneja’s journey from
lists-rankings
When you're sick, going to a pharmacy, waiting in line, and potentially finding out they don't have your medication can be a difficult experience. It’s even more of a challenge if you’re managing a chronic condition that requires regular medication. Fortunately, medicine can now
news
StartupTalky presents Recap'25, a series of exclusive interviews where we connect with founders and industry leaders to reflect on their journey in 2025 and discuss their vision for the future. In this edition of Recap’25, StartupTalky speaks with Akanksha Gupta, Co-founder at MicrobioTx, who shares insights on
Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised ₹14.48 crore in its Pre Series A funding round led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Limited. With over forty years of experience in the pharmaceutical
Zepto, a rapid commerce (qcom) platform, has begun trial testing two additional products in an effort to diversify its offerings and break into new markets. It is now trialling Super Mall, a new vertical for high-value and luxury products, and Zepto Diagnostics, an in-app diagnostics solution within its pharma sector.
An exclusive brand alliance was established on 18 November by AstraZeneca Pharma India and Sun Pharmaceutical Industries to increase the availability of sodium zirconium cyclosilicate (SZC), a therapy for hyperkalaemia, in the Indian market. Both businesses will market and distribute SZC under different brand names as part of the agreement.
news
In this exclusive interaction with StartupTalky, Navy Vijay Ramavat, Managing Director of Indira Securities, shares his insights on reading market signals, navigating volatility, and spotting opportunities amid changing global and domestic trends. He discusses how investors can balance active and passive strategies, benefit from emerging sectors like pharma, engineering, textiles,
The proposed purchase of a portion of JB Chemicals and Pharmaceuticals by Torrent Pharmaceuticals Ltd. was approved by fair trade regulator CCI on 21 October, contingent on voluntary changes made by the parties. The move followed Torrent Pharmaceuticals' announcement in June of this year that it would pay INR
Graph AI, a California-based AI life sciences company focused on patient safety and pharmacovigilance, has raised $3 million in seed funding, led by Bessemer Venture Partners (BVP). The investment will enable Graph AI to accelerate product innovation, expand its engineering team, and drive global market adoption. Graph AI is part
The Danish pharmaceutical company intends to reduce 11% of its workforce, or 9,000 positions, in order to save 8 billion Danish krone ($1.25 billion) a year. Indian workers in Bengaluru have been laid off less than a month after Ozempic manufacturer Novo Nordisk declared it was reducing its
In a major agreement announced on 30 September 2025, pharmaceutical giant Pfizer has struck a deal with the Trump administration to lower the cost of prescription drugs sold to Medicaid, the U.S. government health programme for low-income Americans. Under the deal, Pfizer will match what is known as “most-favoured
After nearly nine years, Emma Walmsley, the CEO of GSK Plc, is leaving her position. Luke Miels, the chief commercial officer of the British pharmaceutical company, will take over as CEO. After working for other large European pharmaceutical companies, Miels joined GSK in 2017 and is now in charge of
news
This article has been contributed by Deepak Kumar Aggarwal, Senior Manager at PwC. When we pick a colorful blister pack or Vial to take our dose of medicine we think of the meticulously manufactured, packed product tested by qualified clinicians behind it. Well, this is true, but a complex well-orchestrated
In a surprise announcement on 25 September, U.S. President Donald Trump said his administration will slap a 100% tariff on branded and patented medicines imported into the United States from 1 October. He made it clear that only drug makers already building plants on U.S. soil would escape
Speciality biotech startup BacAlt Biosciences raises INR 18 Crore in funding round led by Avaana Capital to scale high-performance biopolymers for mass-market applications.
news
This article has been contributed by Dr Vaishaly Bharambe, MBBS, MD, PhD-Anatomy Counsellor and Medical Educator. Founder: VB Anatomy Academy (YouTube channel) There has been a rapid rise in artificial intelligence (AI), and this is reshaping nearly everything in our modern life. So it goes without saying that medicine is
news
Counterfeiting is a growing threat across the FMCG, pharma, and automotive industries, and traditional safeguards are no longer enough. In this exclusive interaction with StartupTalky, Mr. Padmakumar Nair, Founder and CEO of Ennoventure, discusses how smart, tech-driven packaging is reshaping brand protection. He shares insights on invisible signatures, consumer behavior
Ahmedabad, India, August 13, 2025 – Senores Pharmaceuticals Limited (“SPL”), through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA (“SPI”), has signed an agreement today to acquire two products of USFDA-approved Abbreviated New Drug Applications (“ANDAs”) from Teva Pharmaceuticals USA, Inc. The addressable opportunity of the acquired ANDAs in the USA is
Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE™. The capital will enable completion of the ongoing Phase 2 clinical trial in India and support preparations for filing an